sar425899 sanofi dual glp-1 glucagon agonist Focus on Glucagon-like Peptide- 1 Target: Drugs Approved or Designed to Treat Obesity The Road towards Triple Agonists:
Description
Norwood, P
Dela, J.J
These mechanisms are central to restoring function in type 2 diabetes as in that condition glucose does not stimulate adequate Ca 2+ influx
RCT SCALE Study - Liraglutide vs Placebo for Weight Loss in Overweight Nondiabetic Adults, NEJM (2015) [PubMed abstract] The SCALE study enrolled 3731 overweight adults who did not have diabetes Main inclusion criteria BMI 30
Pediatrics (Wegovy only): Ages 1217: BMI 95th percentile standardized for age and sex
